Clinical Trial Update: COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the combination of AmBisome (liposomal amphotericin B) with caspofungin for invasive aspergillosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• Cancidas (caspofungin)

Snippet

Sponsor: Gilead Sciences | Conditions: Invasive Aspergillosis | Phase 4 | Status: COMPLETED